Hennion & Walsh Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.7M | Sell |
|
|||||
|
2025
Q2 | $5.21M | Sell |
|
|||||
|
2025
Q1 | $6.91M | Buy |
|
|||||
|
2024
Q4 | $4.89M | Sell |
|
|||||
|
2024
Q3 | $5.23M | Sell |
|
|||||
|
2024
Q2 | $5.21M | Sell |
|
|||||
|
2024
Q1 | $5.54M | Buy |
|
|||||
|
2023
Q4 | $4.82M | Sell |
|
|||||
|
2023
Q3 | $4.69M | Sell |
|
|||||
|
2023
Q2 | $5.57M | Sell |
|
|||||
|
2023
Q1 | $5.81M | Buy |
|
|||||
|
2022
Q4 | $7.19M | Sell |
|
|||||
|
2022
Q3 | $4.76M | Buy |
|
|||||
|
2022
Q2 | $3.77M | Sell |
|
|||||
|
2022
Q1 | $4.35M | Buy |
|
|||||
|
2021
Q4 | $3.59M | Buy |
|
|||||
|
2021
Q3 | $2.64M | Buy |
|
|||||
|
2021
Q2 | $5.14M | Buy |
|
|||||
|
2021
Q1 | $3.29M | Buy |
|